Video
Author(s):
There can be significant obstacles for healthcare professionals in the United States treating Hispanic and Latino patients, particularly when a language barrier is involved.
There can be significant obstacles for healthcare professionals in the United States treating Hispanic and Latino patients, particularly when a language barrier is involved.
Jaime Davidson, MD, from the University of Texas Southwestern Medical Center at Dallas, discussed a tool developed by Janssen Pharmaceuticals designed to bridge that gap during the American Diabetes Association's 75th Annual Scientific Sessions in Boston.
Known as the Diabetes Medication Options decision aid, Davidson said there are components patients can use at home and with the doctors to help them with their treatment even when English is not their primary language. Among the topics covered by the tool, in both English and Spanish, are the efficacy of treatment options, their safety profiles, and how they're administered as well as costs associated with the therapies. More information about the tool can be found here.
Real-World Study Confirms Similar Efficacy of Guselkumab and IL-17i for PsA